Alector (ALEC) Amortization of Deferred Charges (2025 - 2026)

Alector (ALEC) posted quarterly Amortization of Deferred Charges of $78000.0 for Q1 2026, up 13.04% year-over-year from $69000.0 in Q1 2025, and little changed quarter-over-quarter from $78000.0 in Q4 2025.

Alector (ALEC) Amortization of Deferred Charges (2025 - 2026) Analysis & Trends

Alector (ALEC) has reported Amortization of Deferred Charges for 2 consecutive years, with $78000.0 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Amortization of Deferred Charges rose 13.04% year-over-year to $78000.0; the TTM figure through Mar 2026 stood at $302000.0 (up 337.68% YoY), while the FY2025 annual figure was $293000.0, changed N/A from the prior year.
  • Amortization of Deferred Charges held at $78000.0 in Q1 2026 per ALEC's latest filing, from $78000.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $78000.0 in Q4 2025 and bottomed at $69000.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Alector 218.85 Mn 46.05 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 81,000.00
Jun 30, 2026 81,000.00
Mar 31, 2026 78,000.00
Mar 31, 2026 78,000.00
Dec 31, 2025 78,000.00
Dec 31, 2025 78,000.00
Sep 30, 2025 75,000.00
Sep 30, 2025 75,000.00
Jun 30, 2025 71,000.00
Jun 30, 2025 71,000.00
Mar 31, 2025 69,000.00
Mar 31, 2025 69,000.00